pharmaphorum4d
GSK’s Indian Horlicks sale may fetch over $4 billion
GlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over $4 billion and potentially use the cash for Novartis' buy out deal. Bloomberg ...
Business Insider India4y
The $452 million Unilever-GSK deal had to be changed because India’s love for Horlicks is worth billions
HUL acquired brand Horlicks from GSK for about $398 million (₹ 3,041 crore) for the Indian market. HUL’s parent company Unilever paid around $54 million (₹415 crore) for Horlicks brand for ...